CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 37.36
  • +0.12+0.32%
Trading Dec 23 10:52 CST
12.04BMarket Cap16.33P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tibet Rhodiola Pharmaceutical Holding Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
560.75M
--
+2.37%
EPS
--
0.53
--
--
Analyst Rating
Strong Buy

Dec 22, 2024

Tibet Rhodiola Pharmaceutical Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
--------

Unlock Free Earnings Estimates

Tibet Rhodiola Pharmaceutical Holding Earnings Reports

  • Tibet Nordicang Pharmaceutical Co., Ltd. Report for the third quarter of 2024

    Oct 29 12:00 ET

  • Tibet Rhodiola Pharmaceutical Holding Semi-annual Report for 2023

    Aug 13 12:00 ET

  • Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.

    Aug 13 12:00 ET

  • Tibet Pharmaceutical Report for the First Quarter of 2024

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme MSCI concept
    MSCI concept
    Intraday+0.98%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday+0.82%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+0.37%